Scientists in France pinpoint why STING pathway hasn't been harnessed for cancer therapy yet

Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer treatment. For years, scientists hoped an essential part of the innate immune system that detects foreign DNA in cellular cytoplasm—the STING pathway—could be harnessed for use in cancer immunotherapy.

Read it at Medical Xpress ↗

← Front page